Macquarie Group’s Phibro Animal Health PAHC Stock Holding History
Bought
Maintained
Sold
Other funds holding PAHC
HA
BIP
SGCIA
Macquarie Group's PAHC Position: Q4 2022 in Review
Macquarie Group sold out of Phibro Animal Health (PAHC) in Q4 2022, closing a stake of 1,060 shares — an estimated $21K sold.
Macquarie Group first reported a position in PAHC in Q3 2017 and held it in 20 quarters. The position peaked at $460K in Q2 2018. 132 funds tracked by Wall St. Rank hold PAHC as of Q4 2022.
- Macquarie Group reported no remaining Phibro Animal Health position as of Q4 2022 after selling out during the quarter.
- Macquarie Group sold 1,060 Phibro Animal Health shares in Q4 2022, an estimated $21K.
- Macquarie Group first reported a position in Phibro Animal Health in Q3 2017 and held it in 20 quarters.
- Macquarie Group's Phibro Animal Health position peaked at $460K in Q2 2018.
- 132 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2022.
Based on Macquarie Group's 13F filing for Q4 2022, filed 21 Feb 2023.